India’s COVID-19 Surge Forced Another Abrupt Stop Of US FDA In-Person Inspections

Agency inspectors worked in the country for about a month before the coronavirus infection surge forced another halt.

India COVID-19 map
The FDA stopped inspections in India in March as daily case counts were rising. • Source: Alamy

US Food and Drug Administration inspectors only had about a month to resume in-person inspections in India before a surge of coronavirus infections forced their suspension once again.

Drug-related inspections restarted in February following nearly a year-long pause due to the safety and travel restrictions necessitated by the...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance